Investor relations
Press Releases
Financial targets
571.3 MSEK
Net sales
39.3 MSEK
Operating profit
43,7 %
Gross margin
51 MSEK
Operating cash flow
Boule share
Boule Diagnostics’ share were listed on NASDAQ Stockholm, on June 23, 2011. The number of shareholders is as of September 30, 2024 2,489.
Financial reports
Here you will find Boules financial reports. Last published report is the Interim report Q3
Corporate governance
Boule is a Swedish public company. Boule applies the Swedish Companies Act and its rules and regulations. The company also follows the regulations that apply to listed companies with the NASDAQ OMX Nordic Exchange as well as the Swedish Code of Corporate Governance (the ”Code”). The Code applies to all Swedish listed companies whose shares are listed with a regulated market in Sweden. The code is based on principles of compliance. The company does not expect to deviate from the Code.
Boule as an investment
Boule operates via subsidiaries in Sweden, the USA, Mexico and Russia. The company products are sold globally primarily through more than 200 distributors and partners in more than 100 countries, supported by Boule’s own local sales and support personnel. The Boule shares are listed on Nasdaq Stockholm since 2011
